Literature DB >> 16407846

A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells.

E J Wojcik1, S Sharifpoor, N A Miller, T G Wright, R Watering, E A Tremblay, K Swan, C R Mueller, B E Elliott.   

Abstract

In the normal breast, hepatocyte growth factor (HGF) is primarily expressed by stromal cells, and stimulates in a paracrine manner epithelial cells expressing the HGF receptor (Met). In invasive human breast carcinomas, HGF and Met are frequently overexpressed, possibly establishing an autocrine HGF/Met loop that promotes tumour cell invasion. However, the mechanisms leading to autocrine HGF expression in carcinoma cells are not known. We previously demonstrated a cooperative effect between c-Src and Stat3 in the activation of HGF transcription in mammary carcinoma cells. The present report defines a novel Stat3 consensus site at nt -95 in the HGF promoter that is highly conserved in human and mouse, and is required for c-Src and Stat3 to activate HGF transcription in breast epithelial cells. DNA-protein binding studies demonstrated high affinity binding of a Stat3-containing complex to the nt -95 site. Endogenous Stat3 binding to this region of the HGF promoter in carcinoma cells expressing HGF was demonstrated using a chromatin immunoprecipitation assay. In addition, coexpression of Stat3 and activated c-Src caused increased expression of endogenous HGF mRNA and protein and marked cell scattering in breast epithelial cells. Our results delineate a novel c-Src/Stat3-dependent mechanism that regulates HGF promoter activity, and is linked to transformation of mammary epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407846     DOI: 10.1038/sj.onc.1209306

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair.

Authors:  Arsalan Shabbir; David Zisa; Huey Lin; Michalis Mastri; Gregory Roloff; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-17       Impact factor: 4.733

2.  RhoA-mediated signaling up-regulates hepatocyte growth factor gene and protein expression in response to apoptotic cells.

Authors:  Hyun-Jung Park; Youn-Hee Choi; Young Joo Cho; Peter M Henson; Jihee Lee Kang
Journal:  J Leukoc Biol       Date:  2010-12-10       Impact factor: 4.962

3.  Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis In Vitro.

Authors:  Arsalan Shabbir; Audrey Cox; Luis Rodriguez-Menocal; Marcela Salgado; Evangelos Van Badiavas
Journal:  Stem Cells Dev       Date:  2015-05-20       Impact factor: 3.272

4.  Essential role of Stat3 in PI3K-induced oncogenic transformation.

Authors:  Jonathan R Hart; Lujian Liao; John R Yates; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

5.  Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer.

Authors:  Jihong Ma; Marie C DeFrances; Chunbin Zou; Carla Johnson; Robert Ferrell; Reza Zarnegar
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

6.  Role of Src signal transduction pathways in scatter factor-mediated cellular protection.

Authors:  Saijun Fan; Qinghui Meng; John J Laterra; Eliot M Rosen
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

Review 7.  The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer.

Authors:  Kim Moran-Jones
Journal:  Mol Diagn Ther       Date:  2016-06       Impact factor: 4.074

8.  Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells.

Authors:  Jeannine Garnett; Vaibhav Chumbalkar; Brian Vaillant; Anupama E Gururaj; Kristen S Hill; Khatri Latha; Jun Yao; Waldemar Priebe; Howard Colman; Lisa A Elferink; Oliver Bogler
Journal:  Neoplasia       Date:  2013-01       Impact factor: 5.715

9.  MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells.

Authors:  Lucy Liu; Nicolas Gaboriaud; Konstantina Vougogianopoulou; Yan Tian; Jun Wu; Wei Wen; Leandros Skaltsounis; Richard Jove
Journal:  Cancer Biol Ther       Date:  2013-11-01       Impact factor: 4.742

10.  Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis.

Authors:  X Li; V Placencio; J M Iturregui; C Uwamariya; A-R Sharif-Afshar; T Koyama; S W Hayward; N A Bhowmick
Journal:  Oncogene       Date:  2008-08-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.